Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ULTRAZ: Ozanimod Cell Migration in Ulcerative Colitis
NCT06188637Phase 4Withdrawn
- Sponsor
- Geert D'Haens
- Start
- Aug 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ozanimod in ulcerative colitis (UC), sponsored by Geert D'Haens. Planned start Aug 2024; status: withdrawn.
02
Drugs
ozanimod
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06188637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06188637.